01-03-2006, 08:43 PM
|
#1
|
Senior Member
Join Date: Sep 2005
Location: Spokane/Warden, WA
Posts: 67
|
What will they think of next??
PSYCHIATRIC RESEARCH STUDY
FOR CANCER PATIENTS
The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.
In order to participate, you must:
- Have stage IV cancer and anxiety.
- Be between the ages of 18 - 70.
- Not have cancer that affects the central nervous system or brain function.
- Have no history of major psychiatric disorder.
- Have no kidney disease, abnormal liver functions, diabetes, epilepsy, or cardiovascular disease, including untreated hypertension.
- Not be taking insulin, oral hypoglycemic, anti-seizure, or heart medications.
If you qualify and choose to participate, you will
- Spend two nights at the hospital for medication administration.
- Receive psilocybin, a novel psychoactive medication.
- Get an MRI scan of the brain if you have not had one recently.
For further information call:
Charles S. Grob, MD or the study nurse
at 310-222-3175
1124 W. Carson Street
Torrance, CA 90502-2052
www.rei.edu
|
|
|